Search hospitals > Missouri > Chesterfield
Novo Nordisk Investigational Site
Claim this profileChesterfield, Missouri 63017
Global Leader in Diabetes
Global Leader in Type 2 Diabetes
Conducts research for Type 1 Diabetes
Conducts research for Inflammation
Conducts research for Heart Failure
26 reported clinical trials
0 medical researchers
Summary
Novo Nordisk Investigational Site is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Diabetes, Type 2 Diabetes, Type 1 Diabetes, Inflammation, Heart Failure and other specialties. Novo Nordisk Investigational Site is involved with conducting 26 clinical trials across 12 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Novo Nordisk Investigational Site
Type 2 Diabetes
Non-alcoholic Fatty Liver Disease
Inflammation
Heart Failure
Diabetes
Fatty Liver Disease
CagriSema
for Type 2 Diabetes
This trial tests CagriSema, a combination of semaglutide and cagrilintide, in people with type 2 diabetes. It aims to see if it can better manage blood sugar levels and reduce body weight by increasing insulin and reducing hunger. Semaglutide is known for lowering blood glucose levels and reducing appetite.
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novo Nordisk Investigational Site?
Novo Nordisk Investigational Site is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Diabetes, Type 2 Diabetes, Type 1 Diabetes, Inflammation, Heart Failure and other specialties. Novo Nordisk Investigational Site is involved with conducting 26 clinical trials across 12 conditions. There are 0 research doctors associated with this hospital, such as .